No abstract available
MeSH terms
-
Antiparkinson Agents / therapeutic use
-
Cost-Benefit Analysis
-
Drug Administration Schedule
-
Dyskinesia, Drug-Induced / physiopathology
-
Dyskinesia, Drug-Induced / prevention & control
-
Evidence-Based Medicine / methods
-
Humans
-
Neuroprotective Agents / therapeutic use
-
Parkinson Disease / drug therapy*
-
Parkinson Disease / economics
-
Parkinson Disease / physiopathology
-
Practice Guidelines as Topic
-
Treatment Outcome
Substances
-
Antiparkinson Agents
-
Neuroprotective Agents